查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1790250

伴侣动物骨关节炎市场规模、份额和趋势分析报告：按产品、动物、给药途径、最终用途、地区和细分市场预测，2025 年至 2033 年

Companion Animal Osteoarthritis Market Size, Share & Trends Analysis Report By Product, By Animal, By Route Of Administration, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

伴侣动物骨关节炎市场概览

2024 年全球伴侣动物骨关节炎市场规模估计为 22.9 亿美元，预计到 2033 年将达到 132.7 亿美元，2025 年至 2033 年的复合年增长率为 23.5%。预计推动市场发展的关键因素包括骨关节炎盛行率上升、研发倡议增加、新治疗方法出现、宣传宣传活动增加以及由于诊断技术的进步而导致的骨关节炎 (OA) 治疗的采用率增加。

伴侣动物（尤其是犬、猫和马）中骨关节炎 (OA) 的盛行率不断上升，是全球伴侣动物骨关节炎市场的主要驱动力。仅就犬类而言，根据临床观察和影像学检查结果，估计约有 20% 的 1 岁以上犬会出现 OA 的临床症状，而老年犬的盛行率可能高达 80%。猫类也呈现类似的趋势，虽然 OA 通常未被充分诊断，但在老年猫科动物群中，这一现象正日益受到重视。一些研究表明，高达 90% 的 12 岁以上猫会出现 OA 的影像学症状。马类的 OA 也是运动马匹和赛马表现下降和提前退休的主要原因。

导致骨关节炎盛行率不断上升的因素有很多，包括由于营养和兽医护理的进步而延长的宠物寿命、不断上升的肥胖率（骨关节炎的主要风险因素），以及兽医和饲主的认知度和诊断能力的提高。这些趋势推动了对早期诊断、慢性病管理和疼痛缓解解决方案的需求。

日益加重的负担促使骨关节炎（OA）治疗领域出现大量投资和创新，包括开发新型生技药品、再生疗法（例如干细胞和富血小板血浆）、单株抗体（例如硕腾的Librela和Solensia）以及其他复杂的疼痛管理方法。製药和生物技术公司正在积极开发长效标靶治疗，以提高宠物的依从性并改善其生活质量，尤其是在宠物饲主对高端预防保健的需求日益增长的情况下。同时，兽医就诊次数的激增以及对运动监测和健康计划的日益重视，推动了诊断药物、补充剂、关节支持饮食和復健服务市场的强劲成长。

综合起来，这些流行病学和行为因素不仅扩大了伴侣动物骨关节炎患者的数量，而且还使该疾病成为全球动物保健行业的关键领域，为治疗、诊断和支持性护理解决方案提供了长期增长机会。

儘管在市场上取得了巨大成功并被广泛采用，但像 Librela 这样的针对骨关节炎的单株抗体最近面临着公众争议，包括要求彻底禁止的呼声和表明肌肉骨骼不利事件增加九倍的新数据，这带来了声誉和监管挑战。 FDA 和 EMA 等监管机构加强审查可能会导致更严格的上市后监控、标籤修订和配方限制。短期内，兽医和宠物饲主可能会转向更保守的选择，例如现有的非类固醇消炎剂和补充剂，这可能会减缓生技药品领域的成长。然而，透明的安全测试、改进的药物安全检测和明确的风险效益指南可以恢復信心，并最终巩固 mAb 疗法作为骨关节炎治疗的地位。

目录

第一章调查方法与范围

第二章执行摘要

第三章：伴侣动物骨关节炎市场的趋势与展望

  • 市场体系展望
    • 母市场
    • 子公司市场
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 伴侣动物骨关节炎市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析
    • 主要国家的法规结构
    • 按主要国家和物种分類的动物族群估计数（2021-2024 年）
    • 管道/临床实验室分析
    • COVID-19影响分析

第四章 伴侣动物骨关节炎市场：产品、估计与趋势分析

  • 细分仪表板
  • 伴侣动物骨关节炎市场：产品差异分析
  • 伴侣动物骨关节炎市场规模与趋势分析（按产品划分）（2021-2033 年）
  • 生技药品
    • 干细胞
    • 富血小板血浆（platelet-richplasma）
    • 单株抗体（mAb）
    • 其他生技药品
  • 黏稠补充剂
  • 製药
    • 类固醇
    • NSAIDs
    • 其他的
  • 营养补充品

第五章 伴侣动物骨关节炎市场：依物种的估计与趋势分析

  • 细分仪表板
  • 伴侣动物骨关节炎市场：动物变异分析
  • 伴侣动物骨关节炎市场规模与趋势分析（按动物，2021-2033 年）
  • 狗
  • 猫
  • 马

6. 伴侣动物骨关节炎市场：依给药途径的估计与趋势分析

  • 细分仪表板
  • 伴侣动物骨关节炎市场：给药途径变异分析
  • 伴侣动物骨关节炎市场规模与趋势分析（依管理途径，2021-2033 年）
    • 口服
    • 注射
    • 肌肉注射
    • 关节内
    • 其他注射药物
    • 其他的

7. 伴侣动物骨关节炎市场：最终用途、估计与趋势分析

  • 细分仪表板
  • 伴侣动物骨关节炎市场：最终用途差异分析
  • 2021 年至 2033 年伴侣动物骨关节炎市场规模与趋势分析（依最终用途）
    • 兽医院/诊所
    • 电子商务
    • 其他的

8. 伴侣动物骨关节炎市场：区域、估计与趋势分析

  • 区域仪表板
  • 2024 年及 2033 年伴侣动物骨关节炎市场占有率
  • 区域展望
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 市场参与企业分类
  • 企业市场分析/堆图分析
  • 公司简介
    • Zoetis
    • Boehringer Ingelheim
    • Elanco Animal Health
    • American Regent, Inc.
    • Merck Animal Health（Merck & Co. Inc）
    • Vetoquinol SA
    • Ceva Sante Animale
    • Virbac
    • Biogenesis Bago
    • Ardent Animal Health, Llc
    • PetVivo Holdings, Inc.（Spryng）
    • VetStem Inc.
    • Enso Discoveries
    • Contura Vet US
    • T-Cyte Therapeutics
    • Medrego Llc.
  • 战略地图
    • 合併与收购
  • 伙伴关係和合作
  • 扩张
  • 产品发布
  • 产品核可
  • 其他的
  • 主要企业名单
    • 製造商列表
    • 经销商名单
    • Product Code: GVR-4-68040-667-6

    Companion Animal Osteoarthritis Market Summary

    The global companion animal osteoarthritis market size was estimated at USD 2.29 billion in 2024 and is projected to reach USD 13.27 billion by 2033, growing at a CAGR of 23.5% from 2025 to 2033. Key factors expected to drive the market include the rising prevalence of osteoarthritis, increasing R&D initiative, emerging novel treatments, increasing awareness campaigns, and advancing diagnostic techniques increasing adoption of osteoarthritis (OA) treatment.

    The rising prevalence of osteoarthritis (OA) in companion animals-particularly dogs, cats, and horses-is significantly driving the global companion animal osteoarthritis market. In canines alone, estimates suggest that approximately 20% of dogs over one year of age show clinical signs of OA, and this prevalence can escalate to as high as 80% in older dogs, according to both clinical observations and radiographic studies. Similar trends are observed in felines, where OA is often underdiagnosed but increasingly recognized in aging cat populations, with some studies indicating radiographic signs in up to 90% of cats over 12 years old. Equine OA also remains a leading cause of reduced performance and early retirement, especially in sport and racehorses.

    Several factors are contributing to this increase in OA prevalence, including extended pet lifespans due to advances in nutrition and veterinary care, rising rates of obesity (a major OA risk factor), and improved awareness and diagnostic capabilities among veterinarians and pet owners. These trends are expanding the demand for early diagnosis, chronic disease management, and pain relief solutions.

    This growing burden has catalyzed significant investment and innovation in OA therapeutics, including the development of novel biologics, regenerative therapies (e.g., stem cells and PRP), monoclonal antibodies (such as Zoetis' Librela and Solensia), and other multimodal pain management approaches. Pharmaceutical and biotech companies are actively developing long-acting, targeted therapies that offer better compliance and improved quality of life for pets, particularly as pet owners increasingly seek premium and preventative care. In parallel, the surge in veterinary visits and emphasis on mobility monitoring and wellness programs is reinforcing a robust market for diagnostics, supplements, joint-support diets, and rehabilitation services.

    Altogether, these epidemiological and behavioral factors are not only expanding the companion animal OA patient pool but are also transforming the disease into a cornerstone segment of the global animal health industry-creating long-term growth opportunities across therapeutics, diagnostics, and supportive care solutions.

    Despite strong market performance and widespread adoption of OA-targeting monoclonal antibodies like Librela, the recent public controversy-including calls for outright bans and new data suggesting a nine fold increase in musculoskeletal adverse events-poses a reputational and regulatory challenge. Heightened scrutiny from regulators like the FDA and EMA may result in tougher post market surveillance, label revisions, or prescribing restrictions. In the short term, veterinarians and pet owners might pivot toward more conservative options, such as established NSAIDs or supplements, potentially slowing growth in the biologics segment. However, transparent safety studies, improved pharmacovigilance, and clear risk-benefit guidelines could restore confidence and ultimately solidify the position of mAb therapies as a premium OA treatment-assuming manufacturers respond proactively

    Global Companion Animal Osteoarthritis Market Report Segmentation

    This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the companion animal osteoarthritis market report based on product, animal, route of administration, end use, and region:

    • Product Outlook (Revenue, USD Million, 2021 - 2033)
    • Biologics
      • Stem Cells
      • Platelet-Rich Plasma (PRP)
      • Monoclonal Antibodies (mAb)
      • Other Biologics
    • Viscosupplements
    • Pharmaceuticals
      • Steroids
      • NSAIDS
      • Others
    • Nutritional Supplements
    • Animal Outlook (Revenue, USD Million, 2021 - 2033)
    • Canine
    • Equine
    • Feline
    • Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
    • Oral
    • Injectable
      • Intra-muscular
      • Intra-articular
      • Other Injectable
    • Others
    • End Use Outlook (Revenue, USD Million, 2021 - 2033)
    • Veterinary Hospitals/Clinics
    • E-commerce
    • Others
    • Regional Outlook (Revenue, USD Million, 2021 - 2033)
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Denmark
      • Sweden
      • Norway
    • Asia Pacific
      • Japan
      • India
      • China
      • South Korea
      • Australia
      • Thailand
    • Latin America
      • Brazil
      • Argentina
    • Middle East and Africa (MEA)
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait

    Table of Contents

    Chapter 1. Methodology and Scope

    • 1.1. Market Segmentation and Scope
    • 1.2. Research Methodology
    • 1.3. Information Procurement
      • 1.3.1. Purchased Database
      • 1.3.2. GVR's Internal Database
      • 1.3.3. Secondary Sources
      • 1.3.4. Primary Research
    • 1.4. Information/Data Analysis
    • 1.5. Market Formulation & Visualization
    • 1.6. Data Validation & Publishing
    • 1.7. Model Details
      • 1.7.1. Commodity flow analysis
      • 1.7.2. Global Market: CAGR Calculation
    • 1.8. List of Secondary Sources

    Chapter 2. Executive Summary

    • 2.1. Market Outlook
    • 2.2. Segment Outlook
    • 2.3. Competitive Insights

    Chapter 3. Companion Animal Osteoarthritis Market Variable Trends & Scope

    • 3.1. Market Lineage Outlook
      • 3.1.1. Parent Market
      • 3.1.2. Ancillary Market
    • 3.2. Market Dynamics
      • 3.2.1. Market Driver Analysis
        • 3.2.1.1. Rising Prevalence of Osteoarthitis
        • 3.2.1.2. Increasing R&D Initiatives
        • 3.2.1.3. Emerging Novel Treatments
        • 3.2.1.4. Increasing Awareness Campaigns
        • 3.2.1.5. Advancing Diagnostic Techniques Increasing Adoption of OA Treatment
      • 3.2.2. Market Restraint Analysis
        • 3.2.2.1. Regulatory Hurdles
        • 3.2.2.2. Emerging Adverse Drug Reactions (ADR)
        • 3.2.2.3. Stringent Regulations
      • 3.2.3. Market Opportunity Analysis
      • 3.2.4. Market Challenge Analysis
    • 3.3. Companion Animal Osteoarthritis Market Analysis Tools
      • 3.3.1. Industry Analysis - Porter's
        • 3.3.1.1. Bargaining power of suppliers
        • 3.3.1.2. Bargaining power of buyers
        • 3.3.1.3. Threat of substitution
        • 3.3.1.4. Threat of new entrants
        • 3.3.1.5. Competitive rivalry
      • 3.3.2. PESTEL Analysis
        • 3.3.2.1. Political & Legal landscape
        • 3.3.2.2. Economic and Social landscape
        • 3.3.2.3. Technological landscape
        • 3.3.2.4. Environmental landscape
      • 3.3.3. Regulatory Framework by Key Countries
      • 3.3.4. Estimated Animal Population, by Key Species, by Key Countries, 2021-2024
      • 3.3.5. Pipeline/ Clinical Trials Analysis
      • 3.3.6. COVID-19 Impact Analysis

    Chapter 4. Companion Animal Osteoarthritis Market: Product Estimates & Trend Analysis

    • 4.1. Segment Dashboard
    • 4.2. Companion Animal Osteoarthritis Market: Product Movement Analysis
    • 4.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by product, 2021 to 2033 (USD Million)
    • 4.4. Biologics
      • 4.4.1. Biologics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.2. Stem Cells
        • 4.4.2.1. Stem Cells Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.3. Platelet-Rich Plasma (PRP)
        • 4.4.3.1. Platelet-Rich Plasma (PRP) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.4. Monoclonal Antibodies (mAb)
        • 4.4.4.1. Monoclonal Antibodies (mAb) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.5. Other Biologics
        • 4.4.5.1. Other Biologics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5. Viscosupplements
      • 4.5.1. Viscosupplements Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6. Pharmaceuticals
      • 4.6.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.6.2. Steroids
        • 4.6.2.1. Steroids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.6.3. NSAIDs
        • 4.6.3.1. NSAIDs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.6.4. Others
        • 4.6.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7. Nutritional Supplements
      • 4.7.1. Nutritional Supplements Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

    Chapter 5. Companion Animal Osteoarthritis Market: Animal Estimates & Trend Analysis

    • 5.1. Segment Dashboard
    • 5.2. Companion Animal Osteoarthritis Market: Animal Movement Analysis
    • 5.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by animal, 2021 to 2033 (USD Million)
    • 5.4. Canine
      • 5.4.1. Canine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5. Feline
      • 5.5.1. Feline Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6. Equine
      • 5.6.1. Equine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

    Chapter 6. Companion Animal Osteoarthritis Market: By Route of Administration Estimates & Trend Analysis

    • 6.1. Segment Dashboard
    • 6.2. Companion Animal Osteoarthritis Market: By Route of Administration Movement Analysis
    • 6.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by route of administration, 2021 to 2033 (USD Million)
      • 6.3.1. Oral
        • 6.3.1.1. Oral Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.2. Injectables
        • 6.3.2.1. Injectables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.3. Intra-muscular
        • 6.3.3.1. Intra-muscular Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.4. Intra-articular
        • 6.3.4.1. Intra-articular Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.5. Other Injectables
        • 6.3.5.1. Other Injectables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.6. Others
        • 6.3.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

    Chapter 7. Companion Animal Osteoarthritis Market: By End Use Estimates & Trend Analysis

    • 7.1. Segment Dashboard
    • 7.2. Companion Animal Osteoarthritis Market: By End Use Movement Analysis
    • 7.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by end use, 2021 to 2033 (USD Million)
      • 7.3.1. Veterinary Hospitals/Clinics
        • 7.3.1.1. Veterinary Hospitals/Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 7.3.2. E-commerce
        • 7.3.2.1. E-commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 7.3.3. Others
        • 7.3.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

    Chapter 8. Companion Animal Osteoarthritis Market: Regional Estimates & Trend Analysis

    • 8.1. Regional Dashboard
    • 8.2. Companion Animal Osteoarthritis Market Share, By Region, 2024 & 2033 (USD Million)
    • 8.3. Regional Outlook
    • 8.4. North America
      • 8.4.1. North America Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.4.2. U.S.
        • 8.4.2.1. Key Country Dynamics
        • 8.4.2.2. U.S. Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.4.3. Canada
        • 8.4.3.1. Key Country Dynamics
        • 8.4.3.2. Canada Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.4.4. Mexico
        • 8.4.4.1. Key Country Dynamics
        • 8.4.4.2. Mexico Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5. Europe
      • 8.5.1. Europe Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.5.2. UK
        • 8.5.2.1. Key Country Dynamics
        • 8.5.2.2. UK Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.5.3. Germany
        • 8.5.3.1. Key Country Dynamics
        • 8.5.3.2. Germany Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.5.4. France
        • 8.5.4.1. Key Country Dynamics
        • 8.5.4.2. France Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.5.5. Italy
        • 8.5.5.1. Key Country Dynamics
        • 8.5.5.2. Italy Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.5.6. Spain
        • 8.5.6.1. Key Country Dynamics
        • 8.5.6.2. Spain Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.5.7. Denmark
        • 8.5.7.1. Key Country Dynamics
        • 8.5.7.2. Denmark Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.5.8. Sweden
        • 8.5.8.1. Key Country Dynamics
        • 8.5.8.2. Sweden Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.5.9. Norway
        • 8.5.9.1. Key Country Dynamics
        • 8.5.9.2. Norway Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6. Asia Pacific
      • 8.6.1. Asia Pacific Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.6.2. Japan
        • 8.6.2.1. Key Country Dynamics
        • 8.6.2.2. Japan Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.6.3. China
        • 8.6.3.1. Key Country Dynamics
        • 8.6.3.2. China Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.6.4. India
        • 8.6.4.1. Key Country Dynamics
        • 8.6.4.2. India Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.6.5. Australia
        • 8.6.5.1. Key Country Dynamics
        • 8.6.5.2. Australia Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.6.6. South Korea
        • 8.6.6.1. Key Country Dynamics
        • 8.6.6.2. South Korea Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.6.7. Thailand
        • 8.6.7.1. Key Country Dynamics
        • 8.6.7.2. Thailand Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.7. Latin America
      • 8.7.1. Latin America Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.7.2. Brazil
        • 8.7.2.1. Key Country Dynamics
        • 8.7.2.2. Brazil Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033
      • 8.7.3. Argentina
        • 8.7.3.1. Key Country Dynamics
        • 8.7.3.2. Argentina Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8. Middle East & Africa
      • 8.8.1. Middle East & Africa Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.8.2. South Africa
        • 8.8.2.1. Key Country Dynamics
        • 8.8.2.2. South Africa Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.8.3. Saudi Arabia
        • 8.8.3.1. Key Country Dynamics
        • 8.8.3.2. Saudi Arabia Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.8.4. UAE
        • 8.8.4.1. Key Country Dynamics
        • 8.8.4.2. UAE Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.8.5. Kuwait
        • 8.8.5.1. Key Country Dynamics
        • 8.8.5.2. Kuwait Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)

    Chapter 9. Competitive Landscape

    • 9.1. Market Participant Categorization
    • 9.2. Company Market Position Analysis/ Heap Map Analysis
    • 9.3. Company Profiles
      • 9.3.1. Zoetis
        • 9.3.1.1. Participant's Overview
        • 9.3.1.2. Financial Performance
        • 9.3.1.3. Product Benchmarking
        • 9.3.1.4. Strategic Initiatives
      • 9.3.2. Boehringer Ingelheim
        • 9.3.2.1. Participant's Overview
        • 9.3.2.2. Financial Performance
        • 9.3.2.3. Product Benchmarking
        • 9.3.2.4. Strategic Initiatives
      • 9.3.3. Elanco Animal Health
        • 9.3.3.1. Participant's Overview
        • 9.3.3.2. Financial Performance
        • 9.3.3.3. Product Benchmarking
        • 9.3.3.4. Strategic Initiatives
      • 9.3.4. American Regent, Inc.
        • 9.3.4.1. Participant's Overview
        • 9.3.4.2. Financial Performance
        • 9.3.4.3. Product Benchmarking
        • 9.3.4.4. Strategic Initiatives
      • 9.3.5. Merck Animal Health (Merck & Co. Inc)
        • 9.3.5.1. Participant's Overview
        • 9.3.5.2. Financial Performance
        • 9.3.5.3. Product Benchmarking
        • 9.3.5.4. Strategic Initiatives
      • 9.3.6. Vetoquinol S.A.
        • 9.3.6.1. Participant's Overview
        • 9.3.6.2. Financial Performance
        • 9.3.6.3. Product Benchmarking
        • 9.3.6.4. Strategic Initiatives
      • 9.3.7. Ceva Sante Animale
        • 9.3.7.1. Participant's Overview
        • 9.3.7.2. Financial Performance
        • 9.3.7.3. Product Benchmarking
        • 9.3.7.4. Strategic Initiatives
      • 9.3.8. Virbac
        • 9.3.8.1. Participant's Overview
        • 9.3.8.2. Financial Performance
        • 9.3.8.3. Product Benchmarking
        • 9.3.8.4. Strategic Initiatives
      • 9.3.9. Biogenesis Bago
        • 9.3.9.1. Participant's Overview
        • 9.3.9.2. Financial Performance
        • 9.3.9.3. Product Benchmarking
        • 9.3.9.4. Strategic Initiatives
      • 9.3.10. Ardent Animal Health, Llc
        • 9.3.10.1. Participant's Overview
        • 9.3.10.2. Financial Performance
        • 9.3.10.3. Product Benchmarking
        • 9.3.10.4. Strategic Initiatives
      • 9.3.11. PetVivo Holdings, Inc. (Spryng)
        • 9.3.11.1. Participant's Overview
        • 9.3.11.2. Financial Performance
        • 9.3.11.3. Product Benchmarking
        • 9.3.11.4. Strategic Initiatives
      • 9.3.12. VetStem Inc.
        • 9.3.12.1. Participant's Overview
        • 9.3.12.2. Financial Performance
        • 9.3.12.3. Product Benchmarking
        • 9.3.12.4. Strategic Initiatives
      • 9.3.13. Enso Discoveries
        • 9.3.13.1. Participant's Overview
        • 9.3.13.2. Financial Performance
        • 9.3.13.3. Product Benchmarking
        • 9.3.13.4. Strategic Initiatives
      • 9.3.14. Contura Vet US
        • 9.3.14.1. Participant's Overview
        • 9.3.14.2. Financial Performance
        • 9.3.14.3. Product Benchmarking
        • 9.3.14.4. Strategic Initiatives
      • 9.3.15. T-Cyte Therapeutics
        • 9.3.15.1. Participant's Overview
        • 9.3.15.2. Financial Performance
        • 9.3.15.3. Product Benchmarking
        • 9.3.15.4. Strategic Initiatives
      • 9.3.16. Medrego Llc.
        • 9.3.16.1. Participant's Overview
        • 9.3.16.2. Financial Performance
        • 9.3.16.3. Product Benchmarking
        • 9.3.16.4. Strategic Initiatives
    • 9.4. Strategy Mapping
        • 9.4.. Mergers & Acquisitions
      • 9.4.2. Partnerships & Collaborations
      • 9.4.3. Expansion
      • 9.4.4. Product launch
      • 9.4.5. Product Approval
      • 9.4.6. Others
    • 9.5. List of Key Companies
      • 9.5.1. List of Manufacturers
      • 9.5.2. List of Distributors

    List of Tables

    • Table 1 List of Secondary Sources
    • Table 2 List of Abbreviations
    • Table 3 Global Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 4 Global Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 5 Global Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 6 Global Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 7 Global Companion Animal Osteoarthritis Market, by Region, 2021 - 2033 (USD Million)
    • Table 8 North America Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
    • Table 9 North America Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 10 North America Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 11 North America Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 12 North America Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 13 U.S. Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 14 U.S. Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 15 U.S. Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 16 U.S. Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 17 Canada Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 18 Canada Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 19 Canada Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 20 Canada Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 21 Mexico Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 22 Mexico Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 23 Mexico Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 24 Mexico Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 25 Europe Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
    • Table 26 Europe Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 27 Europe Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 28 Europe Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 29 Europe Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 30 UK Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 31 UK Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 32 UK Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 33 UK Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 34 Germany Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 35 Germany Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 36 Germany Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 37 Germany Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 38 France Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 39 France Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 40 France Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 41 France Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 42 Italy Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 43 Italy Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 44 Italy Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 45 Italy Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 46 Spain Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 47 Spain Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 48 Spain Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 49 Spain Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 50 Denmark Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 51 Denmark Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 52 Denmark Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 53 Denmark Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 54 Sweden Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 55 Sweden Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 56 Sweden Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 57 Sweden Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 58 Norway Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 59 Norway Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 60 Norway Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 61 Norway Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 62 Asia Pacific Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
    • Table 63 Asia Pacific Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 64 Asia Pacific Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 65 Asia Pacific Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 66 Asia Pacific Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 67 China Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 68 China Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 69 China Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 70 China Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 71 Japan Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 72 Japan Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 73 Japan Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 74 Japan Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 75 India Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 76 India Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 77 India Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 78 India Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 79 South Korea Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 80 South Korea Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 81 South Korea Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 82 South Korea Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 83 Australia Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 84 Australia Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 85 Australia Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 86 Australia Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 87 Thailand Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 88 Thailand Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 89 Thailand Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 90 Thailand Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 91 Latin America Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
    • Table 92 Latin America Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 93 Latin America Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 94 Latin America Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 95 Latin America Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 96 Brazil Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 97 Brazil Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 98 Brazil Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 99 Brazil Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 100 Brazil Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 101 Argentina Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 102 Argentina Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 103 Argentina Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 104 Middle East & Africa Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
    • Table 105 Middle East & Africa Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 106 Middle East & Africa Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 107 Middle East & Africa Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 108 Middle East & Africa Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 109 South Africa Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 110 South Africa Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 111 South Africa Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 112 South Africa Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 113 Saudi Arabia Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 114 Saudi Arabia Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 115 Saudi Arabia Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 116 Saudi Arabia Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 117 UAE Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 118 UAE Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 119 UAE Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 120 UAE Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 121 Kuwait Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 122 Kuwait Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 123 Kuwait Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 124 Kuwait Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)

    List of Figures

    • Fig. 1 Market research process
    • Fig. 2 Information Procurement
    • Fig. 3 Primary Research Pattern
    • Fig. 4 Market Research Approaches
    • Fig. 5 Value Chain-Based Sizing & Forecasting
    • Fig. 6 Market Formulation & Validation
    • Fig. 7 Companion Animal Osteoarthritis Market, Market Segmentation
    • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
    • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
    • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
    • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
    • Fig. 12 Porter's Five Forces Analysis
    • Fig. 13 Regional Marketplace: Key Takeaways
    • Fig. 14 Global Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Fig. 15 Global Companion Animal Osteoarthritis Market, for Biologics, 2021 - 2033 (USD Million)
    • Fig. 16 Global Companion Animal Osteoarthritis Market, for Stem Cells, 2021 - 2033 (USD Million)
    • Fig. 17 Global Companion Animal Osteoarthritis Market, for Platelet-Rich Plasma (PRP), 2021 - 2033 (USD Million)
    • Fig. 18 Global Companion Animal Osteoarthritis Market, for Monoclonal Antibodies (mAb), 2021 - 2033 (USD Million)
    • Fig. 19 Global Companion Animal Osteoarthritis Market, for Other Biologics, 2021 - 2033 (USD Million)
    • Fig. 20 Global Companion Animal Osteoarthritis Market, for Viscosupplements, 2021 - 2033 (USD Million)
    • Fig. 21 Global Companion Animal Osteoarthritis Market, for Pharmaceuticals, 2021 - 2033 (USD Million)
    • Fig. 22 Global Companion Animal Osteoarthritis Market, for Steroids, 2021 - 2033 (USD Million)
    • Fig. 23 Global Companion Animal Osteoarthritis Market, for NSAIDS, 2021 - 2033 (USD Million)
    • Fig. 24 Global Companion Animal Osteoarthritis Market, for Others, 2021 - 2033 (USD Million)
    • Fig. 25 Global Companion Animal Osteoarthritis Market, for Nutritional Supplements, 2021 - 2033 (USD Million)
    • Fig. 26 Global Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Fig. 27 Global Companion Animal Osteoarthritis Market, for Canine, 2021 - 2033 (USD Million)
    • Fig. 28 Global Companion Animal Osteoarthritis Market, for Equine, 2021 - 2033 (USD Million)
    • Fig. 29 Global Companion Animal Osteoarthritis Market, for Feline, 2021 - 2033 (USD Million)
    • Fig. 30 Global Companion Animal Osteoarthritis Market, for By Route of Administration, 2021 - 2033 (USD Million)
    • Fig. 31 Global Companion Animal Osteoarthritis Market, for Oral, 2021 - 2033 (USD Million)
    • Fig. 32 Global Companion Animal Osteoarthritis Market, for Injectable, 2021 - 2033 (USD Million)
    • Fig. 33 Global Companion Animal Osteoarthritis Market, for Intra-muscular, 2021 - 2033 (USD Million)
    • Fig. 34 Global Companion Animal Osteoarthritis Market, for Intra-articular, 2021 - 2033 (USD Million)
    • Fig. 35 Global Companion Animal Osteoarthritis Market, for Other Injectable, 2021 - 2033 (USD Million)
    • Fig. 36 Global Companion Animal Osteoarthritis Market, for Others, 2021 - 2033 (USD Million)
    • Fig. 37 Global Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Fig. 38 Global Companion Animal Osteoarthritis Market, for Veterinary Hospitals/Clinics, 2021 - 2033 (USD Million)
    • Fig. 39 Global Companion Animal Osteoarthritis Market, for E-commerce, 2021 - 2033 (USD Million)
    • Fig. 40 Global Companion Animal Osteoarthritis Market, for Others, 2021 - 2033 (USD Million)
    • Fig. 41 Regional Outlook, 2024 & 2033
    • Fig. 42 North America Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 43 U.S. Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 44 Canada Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 45 Mexico Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 46 Europe Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 47 UK Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 48 Germany Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 49 France Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 50 Italy Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 51 Spain Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 52 Sweden Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 53 Denmark Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 54 Norway Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 55 Asia Pacific Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 56 Japan Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 57 China Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 58 India Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 59 Australia Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 60 South Korea Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 61 Thailand Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 62 Latin America Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 63 Brazil Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 64 Argentina Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 65 Middle East and Africa Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 66 South Africa Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 67 Saudi Arabia Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 68 UAE Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 69 Kuwait Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)